Drug Profile
Yersinia pestis vaccine - Introgen Therapeutics/Greenwich LifeSciences Inc/University of Texas Medical Branch
Latest Information Update: 14 Oct 2020
Price :
$50
*
At a glance
- Originator Introgen Therapeutics; Norwell Inc; University of Texas Medical Branch
- Class Plague vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Plague
Most Recent Events
- 27 Jul 2016 Discontinued - Preclinical for Plague in USA (Intranasal)